News
Cutting-Edge Genetic Engineering for Genome Editing
A University of Zürich research team has developed a powerful new method so as to precisely edit DNA by way of combining cutting-edge genetic engineering along with artificial intelligence. This kind of technique opens the doors to more precise...
BioPharma
Pfizer to Expand Use of Padcev in Bladder Cancer
Padcev, which happens to be an antibody drug conjugate that Pfizer has acquired in its $43 billion buyout of Seagen, has gone on to meet the primary objective of a bladder cancer trial, thereby helping people who were ineligible...
News
How Nurses Can Advance Their Careers With the Right Education
Nursing stands among the most dynamic and rewarding healthcare professions, yet the pathways to career advancement within the field require strategic planning and an unwavering commitment to personal and professional growth. As the demands of modern healthcare intensify, many...
News
The FDA PreCheck Program To Speed-Up US Drug Production
The US Food and Drug Administration announced on August 7, 2025, FDA PreCheck, which is a new program in order to strengthen the domestic pharmaceutical supply chain by way of increasing regulatory productivity along with facilitating the construction of...
News
Reshoring Amidst Tariff Cloud – Aurobindo Acquires Lannett
Aurobindo acquires Lannett – the US Drugmaker for $250 million thereby shoring up the Indian drugmaker's footprint in the US in the middle of the threats that the Trump administration plans so as to impose tariffs when it comes...
BioPharma
Medicine Manufacturers from Europe Eyeing US Tariff Move
The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU.
The declaration made by Trump that the drug exports of Europe will be hit with certain...
BioPharma
US Biotech Companies Need Government Aid to Match with China
The lawmakers in Washington have shared the angst of US drugmakers, which have been surpassed by the fast-progressing biotechnology sector of China, but have not raised any alarms on the recent surge within the licensing deals for medicines that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read















